Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX 1,127.50
+77.50 (7.38%)
Mar 9, 2026, 4:46 PM GMT
Hemogenyx Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
72.45M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Faron Pharmaceuticals Oy | 1.14M |
| hVIVO | 54.47M |
| Bioventix | 13.12M |
| 4basebio | 1.78M |
| Ondine Biomedical | 1.18M |
| ImmuPharma | -69.96K |
| Scancell Holdings | 4.71M |
| SkinBioTherapeutics | 4.64M |
Hemogenyx Pharmaceuticals News
- 10 days ago - Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights - Accesswire
- 14 days ago - Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity - Accesswire
- 27 days ago - CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity - Accesswire
- 27 days ago - Hemogenyx Pharmaceuticals PLC Announces Issue of Equity - Accesswire
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares - Accesswire
- 2 months ago - Hemogenyx Pharmaceuticals PLC - Issue of Equity - Accesswire
- 3 months ago - Hemogenyx Pharmaceuticals PLC Announces Publication of Prospectus - Accesswire
- 4 months ago - Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards - Accesswire